Lessened severe graft-versus-host after "minitransplantations"

被引:7
作者
Sorror, M [1 ]
Maris, M [1 ]
Diaconescu, R [1 ]
Storb, R [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
D O I
10.1182/blood-2004-10-4039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2614 / 2614
页数:1
相关论文
共 8 条
  • [1] Do "minitransplantations" have "minitoxicity"?
    Abbott, BL
    [J]. BLOOD, 2004, 104 (05) : 1239 - 1240
  • [2] Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
    Diaconescu, R
    Flowers, CR
    Storer, B
    Sorror, ML
    Maris, MB
    Maloney, DG
    Sandmaier, BM
    Storb, R
    [J]. BLOOD, 2004, 104 (05) : 1550 - 1558
  • [3] Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
    Feinstein, LC
    Sandmaier, BM
    Hegenbart, U
    McSweeney, PA
    Maloney, DG
    Gooley, TA
    Maris, MB
    Chauncey, TR
    Bruno, B
    Appelbaum, FR
    Niederwieser, DW
    Storb, RF
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) : 281 - 288
  • [4] Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
    Maloney, DG
    Molina, AJ
    Sahebi, F
    Stockerl-Goldstein, KE
    Sandmaier, BM
    Bensinger, W
    Storer, B
    Hegenbart, U
    Somlo, G
    Chauncey, T
    Bruno, B
    Appelbaum, FR
    Blume, KG
    Forman, SJ
    McSweeney, P
    Storb, R
    [J]. BLOOD, 2003, 102 (09) : 3447 - 3454
  • [5] Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma
    Maris, MB
    Sandmaier, BM
    Storer, BE
    Chauncey, T
    Stuart, MJ
    Maziarz, RT
    Agura, E
    Langston, AA
    Pulsipher, M
    Storb, R
    Maloney, DG
    [J]. BLOOD, 2004, 104 (12) : 3535 - 3542
  • [6] Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
    Mielcarek, M
    Martin, PJ
    Leisenring, W
    Flowers, MED
    Maloney, DG
    Sandmaier, BM
    Maris, MB
    Storb, R
    [J]. BLOOD, 2003, 102 (02) : 756 - 762
  • [7] Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)
    Sorror, ML
    Maris, MB
    Sandmaier, BM
    Jain-Stuart, M
    Storer, B
    Hegenbart, U
    McSweeney, P
    Chauncey, T
    Bruno, B
    Wade, J
    Agura, E
    Pulsipher, M
    Leis, J
    Little, MT
    Niederwieser, D
    Blume, K
    Storb, R
    Maloney, DG
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 26 - 26
  • [8] Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
    Sorror, ML
    Maris, MB
    Storer, B
    Sandmaier, BM
    Diaconescu, R
    Flowers, C
    Maloney, DG
    Storb, R
    [J]. BLOOD, 2004, 104 (04) : 961 - 968